CVI Investments, Inc. 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 2:01 pm Sale | 2025-06-30 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | CVI Investments, Inc. | 178,580 4.900% | -21,420 (-10.71%) | Filing |
| 2025-07-01 10:18 am Purchase | 2025-06-26 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | CVI Investments, Inc. | 200,000 5.900% | 77,681 (+63.51%) | Filing |
| 2025-02-07 4:10 pm Sale | 2024-12-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | CVI Investments, Inc. | 122,319 4.900% | -44,348 (-26.61%) | Filing |
| 2024-12-23 11:30 am Purchase | 2024-12-16 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | CVI Investments, Inc. | 166,667 7.200% | 166,667 (New Position) | Filing |